Health & Fitness
Health and Fitness
Health and Fitness
Thu, November 11, 2010
Wed, November 10, 2010
SAN DIEGO--([ BUSINESS WIRE ])--DexCom, Inc. (NASDAQ:DXCM) today announced that Terrance Gregg, President and Chief Executive Officer, will present an update on DexCom at several upcoming investor conferences. These conferences include:
- Lazard Capital Markets 7th Annual Healthcare Conference in New York City on Tuesday, November16th, 2010, at 2:40 p.m. (EST). The presentation, which will occur live at the St. Regis Hotel, will be concurrently webcast. The link to the webcast will be available on the DexCom website at [ www.dexcom.com ] under the investor relations, events and webcast section, and will be archived for future reference.
- Stephens Inc. Fall Investment Conference in New York City on Wednesday, November17th, 2010, at 10:00 a.m. (EST). The presentation, which will occur live at the New York Palace Hotel, will be concurrently webcast. The link to the webcast will be available on the DexCom website at [ www.dexcom.com ] under the investor relations, events and webcast section, and will be archived for future reference.
- Piper Jaffray 22nd Annual Health Care Conference in New York City on Wednesday, December 1, 2010, at 11:30 a.m. (EST). The presentation, which will occur live at the New York Palace Hotel, will be concurrently webcast. The link to the webcast will be available on the DexCom website at [ www.dexcom.com ] under the investor relations, events and webcast section, and will be archived for future reference.
In addition, Steven Pacelli, Chief Operating Officer, will present an update on DexCom at the following conference:
- Canaccord Genuity Cardiovascular, Diabetes and Obesity Conference in San Francisco, California on Wednesday, December 8th, 2010, at 10:30 a.m. (PST). The presentation, which will occur live at the Nikko Hotel in San Francisco, will be concurrently webcast. The link to the webcast will be available on the DexCom website at [ www.dexcom.com ] under the investor relations, events and webcast section, and will be archived for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.
Cautionary Statement Regarding Forward Looking Statements
DexCom is a medical device company with a limited operating history. Successful commercialization of the companya™s products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the companya™s development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the companya™s annual report on Form 10-Q for the period ending September30, 2010, as filed with the Securities and Exchange Commission on November 4, 2010.
